©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 28, 2010; 16(44): 5543-5554
Published online Nov 28, 2010. doi: 10.3748/wjg.v16.i44.5543
Published online Nov 28, 2010. doi: 10.3748/wjg.v16.i44.5543
Table 1 Lugano staging classification of gastrointestinal tract lymphoma[29]
| Stage | |
| I | Tumor confined to GI tract |
| Stage primary site or multiple, noncontiguous lesions | |
| II | Tumor extending into abdomen from primary GI site |
| Nodal involvement | |
| II1 | Local (paragastric in cases of gastric lymphoma and paraintestinal for intestinal lymphoma) |
| II2 | Distant (mesenteric in the case of an intestinal primary; otherwise paraaortic, paracaval, pelvic, inguinal) |
| IIE | Penetration of serosa to involve adjacent organs or tissues [enumerate actual site of involvement, e.g. IIE (pancreas), IIE (large intestine), IIE (post intestinal wall)] |
| Where there is both nodal involvement and penetration involving adjacent organs, the stage is denoted using both a subscript (1 or 2) and E, e.g. II1E (pancreas) | |
| IV | Disseminated extra-nodal involvement, or a GI tract lesion with supradiaphragmatic nodal involvement |
- Citation: Watanabe T. Treatment strategies for nodal and gastrointestinal follicular lymphoma: Current status and future development. World J Gastroenterol 2010; 16(44): 5543-5554
- URL: https://www.wjgnet.com/1007-9327/full/v16/i44/5543.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i44.5543